SBIO: Leaning Into Drug Discovery And Medical Breakthroughs
Source: SeekingAlpha
2026-04-28 10:41:53 ET
Launched in late 2014 (when the “ Four Horseman of Biotech ” was still a thing), the ALPS Medical Breakthroughs ETF ( SBIO ) is a fund that invests in a concentrated portfolio of biotech companies with drugs that are presently in Phase II or Phase III of FDA clinical trials. ...
Read the full article on Seeking Alpha
For further details see:
SBIO: Leaning Into Drug Discovery And Medical Breakthroughs
Amicus Therapeutics Inc.
NASDAQ: FOLD
FOLD Trading
0.24% G/L:
$14.50 Last:
2,388,212 Volume:
$14.49 Open:
FOLD Latest News
April 25, 2026 11:33:12 am
CIBRA Capital Makes a Big Merger Arbitrage Bet On Amicus Therapeutics (FOLD)
February 20, 2026 04:01:00 pm
Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates
FOLD Stock Data
$4,416,657,740
301,745,810
0.4%
110
N/A
Biotechnology & Life Sciences
Healthcare
US
Princeton
